Saturday, December 5, 2020

Bluebird (BLUE) Down 3.8% Since Last Earnings Report: Can It Rebound?

In September 2020, the company announced that its investigational pipeline candidate for sickle cell disease (SCD) gene therapy, LentiGlobin, was ...
http://dlvr.it/Rn27Sj
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...